Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Carrimycin Treatment in Patients With Novel Coronavirus Infectious Disease (COVID-19) : A Multicenter, Randomized, Open-controlled Study

NCT04286503 is registered in ClinicalTrials.gov with Beijing YouAn Hospital as lead sponsor.

NCT NCT04286503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04286503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Carrimycin Treatment in Patients With Novel Coronavirus Infectious Disease (COVID-19) : A Multicenter, Randomized, Open-controlled Study
Lead sponsor
Beijing YouAn Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
February 23, 2020
Completion date
February 28, 2021
Enrollment
520 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

novel coronavirus infectious disease (covid-19)